Viewing Study NCT06507202



Ignite Creation Date: 2024-10-26 @ 3:35 PM
Last Modification Date: 2024-10-26 @ 3:35 PM
Study NCT ID: NCT06507202
Status: RECRUITING
Last Update Posted: None
First Post: 2024-01-18

Brief Title: Comparison of Remimazolam and Propofol for Recovery of Ambulatory Upper Airway Surgery
Sponsor: None
Organization: None

Study Overview

Official Title: Comparison of Remimazolam Versus Propofol-based General Anesthesia on Postoperative Quality of Recovery in Patients Undergoing Ambulatory Upper Airway Surgery a Randomized Controlled Trial
Status: RECRUITING
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to compare the effects of remimazolam and propofol on postoperative recovery time complications and safety in patients undergoing ambulatory upper airway surgery under general anesthesia
Detailed Description: Patients scheduled for ambulatory upper airway including nasal cavity oral cavity pharynx larynx surgery and who agree to participate in the study will be randomly assigned to the Remimazolam group and the Propofol group In the Remimazolam group general anesthesia is induced and maintained by continuous infusion of remimazolam and remifentanil Once the surgery is completed general anesthesia is recovered with flumazenil In the Propofol group general anesthesia is induced and maintained by continuous infusion of propofol and remifentanil using a target concentration controlled infusion method In both groups rocuronium is used for neuromuscular blokade and sugammadex is used for reversal of neuromuscular blockade

When the surgery is completed recovery time occurrence of adverse events and anesthesia recovery indicators are examined in 3 stages in the operating room while staying in the post-anesthesia care unitPACU and while staying in the day surgery center

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None